Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CMC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100996740 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ICAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDAH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DROSHA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C21orf33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMOD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLPP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
P2RX7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARID5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on